Clearstead Advisors, LLC Cor Medix Inc. Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 2 shares of CRMD stock, worth $22. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2Holding current value
$22% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRMD
# of Institutions
199Shares Held
34.3MCall Options Held
867KPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA3.98MShares$44.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$39.8 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$28.9 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA1.81MShares$20.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$19.2 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $462M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...